Travere Therapeutics names Bradley L. Campbell as CEO

Travere Therapeutics appointed Bradley L. Campbell as President and Chief Executive Officer and board member effective December 1, 2026. Eric Dube will step down from those roles and become Executive Advisor and consultant.